These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 20093607

  • 1. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
    Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C, Aisen AM.
    AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
    [Abstract] [Full Text] [Related]

  • 2. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H.
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
    Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A, Iyer VK, Das P.
    Acta Radiol; 2012 Apr 01; 53(3):349-58. PubMed ID: 22496427
    [Abstract] [Full Text] [Related]

  • 4. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
    Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J.
    AJR Am J Roentgenol; 2010 Nov 01; 195(5):W344-51. PubMed ID: 20966299
    [Abstract] [Full Text] [Related]

  • 5. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA, Kim CK, Park SY, Cho SW, Park BK.
    AJR Am J Roentgenol; 2014 Jul 01; 203(1):W78-84. PubMed ID: 24951231
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G, Koc Z, Karadeli E, Kuzgunbay B, Goren MR, Bal N.
    Acta Radiol; 2012 Apr 01; 53(3):359-65. PubMed ID: 22334870
    [Abstract] [Full Text] [Related]

  • 7. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification.
    Inci E, Hocaoglu E, Aydin S, Cimilli T.
    Eur J Radiol; 2012 May 01; 81(5):815-20. PubMed ID: 21377306
    [Abstract] [Full Text] [Related]

  • 8. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
    Rheinheimer S, Stieltjes B, Schneider F, Simon D, Pahernik S, Kauczor HU, Hallscheidt P.
    Eur J Radiol; 2012 Mar 01; 81(3):e310-6. PubMed ID: 22104090
    [Abstract] [Full Text] [Related]

  • 9. Diffusion-weighted imaging of the renal and adrenal lesions.
    Kilickesmez O, Inci E, Atilla S, Tasdelen N, Yetimoğlu B, Yencilek F, Gurmen N.
    J Comput Assist Tomogr; 2009 Mar 01; 33(6):828-33. PubMed ID: 19940645
    [Abstract] [Full Text] [Related]

  • 10. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.
    Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H.
    Radiology; 2008 May 01; 247(2):458-64. PubMed ID: 18430878
    [Abstract] [Full Text] [Related]

  • 11. Utility of diffusion-weighted MRI in characterization of adrenal lesions.
    Miller FH, Wang Y, McCarthy RJ, Yaghmai V, Merrick L, Larson A, Berggruen S, Casalino DD, Nikolaidis P.
    AJR Am J Roentgenol; 2010 Feb 01; 194(2):W179-85. PubMed ID: 20093571
    [Abstract] [Full Text] [Related]

  • 12. Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI.
    Mytsyk Y, Dutka I, Yuriy B, Maksymovych I, Caprnda M, Gazdikova K, Rodrigo L, Kruzliak P, Illjuk P, Farooqi AA.
    Int Urol Nephrol; 2018 Feb 01; 50(2):197-204. PubMed ID: 29230706
    [Abstract] [Full Text] [Related]

  • 13. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
    Kim S, Jain M, Harris AB, Lee VS, Babb JS, Sigmund EE, Rueff LE, Taouli B.
    Radiology; 2009 Jun 01; 251(3):796-807. PubMed ID: 19380690
    [Abstract] [Full Text] [Related]

  • 14. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
    Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM.
    Radiology; 2009 May 01; 251(2):398-407. PubMed ID: 19276322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
    Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD.
    AJR Am J Roentgenol; 2010 Jun 01; 194(6):1664-73. PubMed ID: 20489111
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y, Liu Q.
    J Comput Assist Tomogr; 2012 Jun 01; 36(4):361-6. PubMed ID: 22805661
    [Abstract] [Full Text] [Related]

  • 19. Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density.
    Ginat DT, Mangla R, Yeaney G, Johnson M, Ekholm S.
    AJR Am J Roentgenol; 2012 Jun 01; 198(6):W597-601. PubMed ID: 22623576
    [Abstract] [Full Text] [Related]

  • 20. ADC measurement of abdominal organs and lesions using parallel imaging technique.
    Yoshikawa T, Kawamitsu H, Mitchell DG, Ohno Y, Ku Y, Seo Y, Fujii M, Sugimura K.
    AJR Am J Roentgenol; 2006 Dec 01; 187(6):1521-30. PubMed ID: 17114546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.